![Mark Berger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 025 $ al 31/07/2026
Mark S.
Berger is currently Chief Medical Officer at Genprex, Inc. since 2021.
Former positions include Senior Director-Oncology Clinical Development at Wyeth Pharmaceuticals LLC; Group Director-Clinical Oncology at GSK Plc from 2002 to 2007; Principal at the University of Pennsylvania; Vice President-Clinical Development at Gemin X Pharmaceuticals US, Inc. from 2007 to 2011; Chief Medical Officer at Deciphera Pharmaceuticals LLC from 2011 to 2013; Senior Vice President-Clinical Research at Kadmon Corp.
LLC from 2013 to 2017; and Chief Medical Officer at Actinium Pharmaceuticals, Inc. from 2017 to 2021.
Education includes undergraduate studies at Wesleyan University and a doctorate from The University of Virginia School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GENPREX INC 0,07 % | 15/04/2026 | 338 ( 0,07 % ) | 2 025 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GENPREX, INC. | Director Técnico/Científico/I+D | 27/09/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 24/09/2021 |
Kadmon Corp. LLC
 Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Director Técnico/Científico/I+D | 01/01/2017 |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations | Director Técnico/Científico/I+D | 01/09/2013 |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Corporate Officer/Principal | 01/06/2011 |
| GSK PLC | Corporate Officer/Principal | 01/02/2007 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Genprex, Inc.
 Genprex, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular therapies for cancer treatment | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Health Technology |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations | Health Technology |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
The University of Virginia School of Medicine
 The University of Virginia School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
